Pathophysiology and Treatment of Psychosis in Parkinson's Disease: A Review

Author： Zahodne Laura B.   Fernandez Hubert H.  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.25, Iss.8, 2008-01, pp. : 665-682

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cognitive Deficits and Psychosis in Parkinson's Disease: A Review of Pathophysiology and Therapeutic Options

By Williams-Gray Caroline H.   Foltynie Thomas   Lewis Simon J.G.   Barker Roger A.  

CNS Drugs, Vol. 20, Iss. 6, 2006-01 ,pp. : 477-505

Adis International

Access to resources Recommend Favorite

Pimavanserin for the treatment of Parkinson's disease psychosis

By Friedman Joseph H  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 14, 2013-10 ,pp. : 1969-1975

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Psychosis in Parkinson’s Disease: Safety Considerations

By Fernandez H.H.   Trieschmann M.E.   Friedman J.H.  

Drug Safety, Vol. 26, Iss. 9, 2003-01 ,pp. : 643-659

Adis International

Access to resources Recommend Favorite

Physical and Mental Fatigue in Parkinson's Disease: Epidemiology, Pathophysiology and Treatment

By Lou Jau-Shin  

Drugs & Aging, Vol. 26, Iss. 3, 2009-01 ,pp. : 195-208

Adis International

Access to resources Recommend Favorite

Depression in Patients with Parkinson's Disease: Epidemiology, Pathophysiology and Treatment Options

By Zesiewicz T.A.  

CNS Drugs, Vol. 13, Iss. 4, 2000-04 ,pp. : 253-264

Adis International

Access to resources Recommend Favorite